125256-00-0
125256-00-0
Chemical Structure
Fatostatin
Synonym(s): 125B11
- CAS No.: 125256-00-0
- Formula:C18H18N2S
- Molecular Weight:294.41
IUPAC Name: 2-(2-propylpyridin-4-yl)-4-(p-tolyl)thiazole
InChIKey: ZROSUBKIGBSZCG-UHFFFAOYSA-N
SMILES: CCCC1=NC=CC(C2=NC(C3=CC=C(C)C=C3)=CS2)=C1
Biological Activity: Fatostatin (125B11), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin decreases the transcription of lipogenic genes in cells. Fatostatin possesses antitumor properties, and lowers hyperglycemia in ob/ob mice[1][2].
| Cat. No. | Product Name | Purity | Description | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
Fatostatin | 99.85% | Fatostatin (125B11), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin decreases the transcription of lipogenic genes in cells. Fatostatin possesses antitumor properties, and lowers hyperglycemia in ob/ob mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
Fatostatin (Standard) | ≥98% | Fatostatin (Standard) is the analytical standard of Fatostatin (HY-14452). This product is intended for research and analytical applications. Fatostatin (125B11), a specific inhibitor of SREBP activation, impairs the activation of SREBP-1 and SREBP-2. Fatostatin binds to SCAP (SREBP cleavage-activating protein), and inhibits the ER-Golgi translocation of SREBPs. Fatostatin decreases the transcription of lipogenic genes in cells. Fatostatin possesses antitumor properties, and lowers hyperglycemia in ob/ob mice. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Choi Y, et al. Identification of bioactive molecules by adipogenesis profiling of organic compounds. J Biol Chem. 2003 Feb 28;278(9):7320-4. [Content Brief]
- [2]. Kamisuki S, et al. A small molecule that blocks fat synthesis by inhibiting the activation of SREBP. Chem Biol. 2009 Aug 28;16(8):882-92. [Content Brief]
